Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases
- Published:18. Jun 2022
- Link:https://link.springer.com/epdf/10.1186/s12885-022-09770-3?sharing_token=VWH0gRy0G5eSslvukhPX5W_BpE1tBhCbnbw3BuzI2RMcH4E1QlfH3KrUUsxiwzOQYkLxckBLp5mv17epjZXfhcyysIpks0AqF6jf36YB6wUTCf2E4PMPXmRwzEE0CF2Xds4bve4xCNLWdbXW1bmWcWlWQJW2uV07AIdpO2YMtmw%3D
- Authors:Stefano Guadagni, Francesco Masedu, Giammaria Fiorentini, Donatella Sarti, Caterina Fiorentini, Veronica Guadagni, Panagiotis Apostolou, Ioannis Papasotiriou, Panagiotis Parsonidis, Marco Valenti, Enrico Ricevuto, Gemma Bruera, Antonietta R. Farina, Andrew R. Mackay and Marco Clementi
Find out more about the scientific basis of RGCC tests